Table 1

Demographics characteristics and clinical manifestations of the KD group

KD groupFebrile groupHealthy groupP value
IVIG non-response groupIVIG response group
Number17543027
Age, median (IQR)1.75 (0.92, 3.59)2.21 (1.17, 3.42)3.54 (1.50, 4.34)3.00 (2.00, 3.00)0.074
Gender
 Male (%)13 (76.47%)27 (50.00%)19 (63.33%)16 (59.26%)0.806
 Female (%)4 (23.53%)27 (50.00%)11 (36.67%)11 (40.74%)
Days of fever, median (IQR)5.00 (5.00, 11.00)5.00 (5.00, 6.00)0.547
Conjunctiva infection (%)14 (82.35%)50 (92.59%)0.442
Cervical lymphadenopathy (%)16 (94.12%)42 (77.78%)0.246
Polymorphous exanthema (%)11 (64.71%)43 (79.63%)0.352
Fissure lips (%)11 (64.71%)40 (74.07%)0.660
Strawberry tongue (%)10 (58.82%)37 (68.52%)0.461
Oedema in the extremities (%)12 (70.59%)42 (77.78%)0.780
  • IVIG, intravenous immunoglobulin; KD, Kawasaki disease.